Literature DB >> 11675637

Modeling in vivo recovery of intracellular pH in muscle to provide a novel index of proton handling: application to the diagnosis of mitochondrial myopathy.

J T Chen1, T Taivassalo, Z Argov, D L Arnold.   

Abstract

Post-exercise recovery of intracellular pH (pH(i)) assessed using phosphorus magnetic resonance spectroscopy has not been previously evaluated in its entirety due to its complex time-course and missing data points resulting from a transient loss of inorganic phosphate signal. By considering the transition from exercise to recovery as a step function input, pH(i) recovery was modeled based on the creatine-kinase equilibrium, and the entire pH(i) recovery was characterized by calculating the time required for pH(i) recovery (t(pHrec)). Applying this methodology, normal subjects showed a strong linear correlation between phosphocreatine (PCr) half-time and t(pHrec) (r = 0.90, P < 0.001). In mitochondrial myopathy (MM) patients with weakness in the limb examined, 9/10 had faster pH(i) recovery relative to PCr recovery; wide normal ranges from a control group which included deconditioned subjects resulted in 7 of those 10 patients having otherwise normal recovery indices. Therefore, modeling pH(i) recovery allows characterization of the entire pH(i) recovery and detects altered proton handling in MM patients, including those with otherwise normal recovery indices. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11675637     DOI: 10.1002/mrm.1271

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  2 in total

1.  31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.

Authors:  Tina Dysgaard Jeppesen; Bjørn Quistorff; Flemming Wibrand; John Vissing
Journal:  J Neurol       Date:  2007-02-04       Impact factor: 4.849

2.  Supplemental oxygen and muscle metabolism in mitochondrial myopathy patients.

Authors:  Michael I Trenell; Carolyn M Sue; Campbell H Thompson; Graham J Kemp
Journal:  Eur J Appl Physiol       Date:  2007-01-12       Impact factor: 3.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.